title: KRAS oncogene rearrangements and gene fusions: unexpected rare encounters in late-stage prostate cancers.
abstract: Wang and colleagues identify a fusion between UBE2L3 and KRAS in a subset of metastatic prostate cancers.
authors.affiliation: Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
authors.forename: Henrik
authors.initials: H
authors.lastname: Edgren
authors.forename: Sara
authors.initials: S
authors.lastname: Kangaspeska
authors.forename: Olli
authors.initials: O
authors.lastname: Kallioniemi
mesh_terms: D000818:Animals; D015321:Gene Rearrangement; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics*; D018631:ras Proteins / Q000235:genetics*
chemical_list: C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; C495971:Hras protein, mouse; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins